Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Lower-Risk MDS: Diagnosis and Treatment Options

    ... neutrophil count less than 1,800/uL and platelet count less than 100,000/mm3. The second criterion is the ... anemia , or a low white blood cell count, or is it a low platelet count?   Anemia is the most frequent problem in MDS, affecting ...

    Interview last updated 05/18/2012 - 1:28pm.

  2. What is a complete blood count test (CBC)?

    ... number is about 3 times the hemoglobin . Platelet count measures the number of platelets in a given volume of ...

    FAQ last updated 04/28/2016 - 4:53pm.

  3. Growth Factors in Aplastic Anemia, MDS, and PNH: Current Thinking on their Use, Risks, and Benefits

    ... red blood cell , white blood cell , or platelet counts. In this webinar, Dr. Akhtari will discuss the role and biology of red blood cells, white blood cells, and platelet growth factors in patients with aplastic anemia , MDS, and PNH ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  4. A Phase I Study to Assess the Safety APL-2 as an Add-On to Standard of Care in Subjects With PNH

    ... one transfusion within 12 months prior to screening Platelet count of >30,000/mm3 Absolute neutrophil count > ...

    Clinical Trial last updated 08/24/2016 - 11:15am.

  5. David Araten, MD

    ... clotting problems, and they tended to have much higher platelet counts than typically seen in patients with PNH. This led us to ... a blood clot . This number can be estimated from the platelet count and the percentage of PNH white cells. In the past there have ...

    Grant Recipient last updated 11/30/2016 - 10:51am.

  6. Overlap Syndromes: When PNH Appears with Aplastic Anemia or MDS

    ... marrow), a chronically high white blood cell or platelet count, especially if they have the JAK2 mutation . Does ... may not be not be able to receive anticoagulants if their platelet count is low. Conversely, for a PNH/aplastic anemia patient, there ...

    Interview last updated 05/14/2015 - 1:53pm.

  7. Extended Dosing With Eltrombopag for Severe Aplastic Anemia

    ... from infection or bleeding, and they require regular platelet and/or red blood cell transfusions, which are expensive ... was first identified as the principal protein regulating platelet production, and it stimulates the proliferation of megakaryocytes and ...

    Clinical Trial last updated 04/26/2016 - 9:36am.

  8. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... c.  At least one cytopenia (ANC < 1800/L or platelet count < 100,000/L or hemoglobin [Hgb] <10 g/dL) ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  9. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of thrombopoietin receptor agonists in aplastic anemia and myelodysplastic syndromes.

    ... causes for complications in both diseases. Blood and platelet transfusions are frequently necessary, but transfusions are ... TPOR is not only expressed on megakaryocytes (the platelet forming cells) but also on bone marrow stem cells that give ...

    Research Review last updated 05/02/2016 - 9:21am.

  10. A Phase I Study to Assess the Safety APL-2 as an Add-On to Standard of Care in Subjects with PNH

    ... within 12 months prior to screening Platelet count of > 30,000/mm3 Absolute neutrophil ...

    Clinical Trial last updated 07/19/2016 - 12:46pm.